Published in J Antimicrob Chemother on February 01, 2000
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis (2004) 2.35
Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob Agents Chemother (2003) 1.78
Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol (2002) 1.71
Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.56
Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy. J Clin Microbiol (2003) 1.53
Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. J Clin Microbiol (2004) 1.43
Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol (2004) 1.40
Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg Infect Dis (2005) 1.12
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study. J Clin Microbiol (2001) 1.11
Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. J Clin Microbiol (2003) 1.10
Macrolide resistance in Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother (2001) 1.10
Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E). Antimicrob Agents Chemother (2005) 1.05
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother (2006) 1.04
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. Antimicrob Agents Chemother (2001) 0.98
DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci. Antimicrob Agents Chemother (2006) 0.97
Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J Clin Microbiol (2005) 0.90
Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000. Antimicrob Agents Chemother (2003) 0.89
Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong. Antimicrob Agents Chemother (2003) 0.87
Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey. J Clin Microbiol (2003) 0.82
Inference of antibiotic resistance and virulence among diverse group A Streptococcus strains using emm sequencing and multilocus genotyping methods. PLoS One (2009) 0.80
The Treatment of Severe Group A Streptococcal Infections. Curr Infect Dis Rep (2003) 0.80
Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients. Antimicrob Agents Chemother (2005) 0.79
High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin. Antimicrob Agents Chemother (2004) 0.77
Macrolide resistance in Streptococcus pneumoniae strains collected in the Far East of Russia from 2000 to 2002. J Clin Microbiol (2003) 0.75
Genetic diversity and exotoxin A production of group A streptococci causing sepsis. J Korean Med Sci (2006) 0.75
Compilation of small ribosomal subunit RNA structures. Nucleic Acids Res (1993) 11.07
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol (2000) 4.71
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ (2009) 3.95
A quantitative map of nucleotide substitution rates in bacterial rRNA. Nucleic Acids Res (1996) 3.90
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect (2004) 3.71
Guidelines for the management of adult lower respiratory tract infections. Eur Respir J (2005) 3.51
Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol (1999) 3.19
Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother (2006) 3.09
Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect (2011) 2.99
Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol (1997) 2.95
Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ (2010) 2.80
Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. Euro Surveill (2014) 2.65
Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments. J Clin Microbiol (1993) 2.54
Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int J Syst Bacteriol (1999) 2.52
Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis (1996) 2.51
Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J Clin Microbiol (1995) 2.43
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet (1989) 2.41
Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest (2000) 2.41
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol (2001) 2.38
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill (2012) 2.29
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol (1986) 2.25
Riemerella anatipestifer gen. nov., comb. nov., the causative agent of septicemia anserum exsudativa, and its phylogenetic affiliation within the Flavobacterium-Cytophaga rRNA homology group. Int J Syst Bacteriol (1993) 2.24
Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol (2000) 2.20
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA (1999) 2.16
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. Eur Respir J (2011) 2.13
Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev (1997) 2.11
Arcobacter species in humans. Emerg Infect Dis (2004) 2.11
Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J Clin Microbiol (2001) 2.09
Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother (1996) 2.06
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Campylobacter upsaliensis enteritis associated with canine infections. Lancet (1991) 2.05
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol (1995) 2.04
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis (2001) 2.04
A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol (1983) 2.03
Development of a multiplex PCR assay for the simultaneous detection and identification of Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii. FEMS Microbiol Lett (2000) 2.01
Ralstonia taiwanensis sp. nov., isolated from root nodules of Mimosa species and sputum of a cystic fibrosis patient. Int J Syst Evol Microbiol (2001) 1.98
Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend. Int J Syst Evol Microbiol (2001) 1.94
Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91
Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol (2000) 1.82
Chemotaxonomic analyses of Bacteroides gracilis and Bacteroides ureolyticus and reclassification of B. gracilis as Campylobacter gracilis comb. nov. Int J Syst Bacteriol (1995) 1.81
Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens. J Clin Microbiol (2006) 1.73
Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. Int J Syst Evol Microbiol (2001) 1.73
Development of species-specific DNA probes for Campylobacter jejuni, Campylobacter coli, and Campylobacter lari by polymerase chain reaction fingerprinting. J Clin Microbiol (1993) 1.67
Utility of an internal control for the polymerase chain reaction. Application to detection of Mycoplasma pneumoniae in clinical specimens. APMIS (1992) 1.66
Burkholderia phytofirmans sp. nov., a novel plant-associated bacterium with plant-beneficial properties. Int J Syst Evol Microbiol (2005) 1.66
Database on the structure of large ribosomal subunit RNA. Nucleic Acids Res (1994) 1.65
Bacteremia caused by a novel Bordetella species, "B. hinzii". J Clin Microbiol (1994) 1.63
Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother (2001) 1.62
Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol (2003) 1.61
Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus. J Clin Microbiol (1999) 1.61
Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol (2001) 1.61
Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol (1996) 1.58
Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol (1996) 1.58
Performance of the recommendations of a British advisory group for screening for chlamydia in a sample of women in general practice. J Med Screen (2003) 1.56
European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol (2004) 1.54
Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol (1997) 1.54
Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol (2001) 1.54
Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin Microbiol Infect (2000) 1.54
Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int J Syst Bacteriol (1999) 1.53
Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52
Evaluation of arbitrarily primed PCR analysis and pulsed-field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine. Int J Syst Bacteriol (1997) 1.50
Primary graft failure caused by herpes simplex virus type 1. Cornea (2001) 1.50
Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients. J Hosp Infect (2003) 1.47
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
Evaluation of the discriminatory power of typing methods for Neisseria gonorrhoeae. J Clin Microbiol (1999) 1.39
Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection. Eur Respir J (2011) 1.39
Burkholderia cepacia genomovar III Is a common plant-associated bacterium. Appl Environ Microbiol (2001) 1.39
Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg (1996) 1.38
Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients. J Clin Microbiol (1999) 1.37
Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis (2011) 1.36
Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol (2008) 1.36
Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35
Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants. J Clin Microbiol (1998) 1.34